AILERON THERAPEUTICS INC - FORM S-1 - EX-23.1 - June 2, 2017

Attached files

file filename
EX-10.14 - EX-10.14 - AILERON THERAPEUTICS INCd14176dex1014.htm
EX-10.19 - EX-10.19 - AILERON THERAPEUTICS INCd14176dex1019.htm
EX-10.18 - EX-10.18 - AILERON THERAPEUTICS INCd14176dex1018.htm
EX-10.17 - EX-10.17 - AILERON THERAPEUTICS INCd14176dex1017.htm
EX-10.16 - EX-10.16 - AILERON THERAPEUTICS INCd14176dex1016.htm
EX-10.15 - EX-10.15 - AILERON THERAPEUTICS INCd14176dex1015.htm
EX-10.13 - EX-10.13 - AILERON THERAPEUTICS INCd14176dex1013.htm
EX-10.7 - EX-10.7 - AILERON THERAPEUTICS INCd14176dex107.htm
EX-10.6 - EX-10.6 - AILERON THERAPEUTICS INCd14176dex106.htm
EX-10.5 - EX-10.5 - AILERON THERAPEUTICS INCd14176dex105.htm
EX-10.4 - EX-10.4 - AILERON THERAPEUTICS INCd14176dex104.htm
EX-10.3 - EX-10.3 - AILERON THERAPEUTICS INCd14176dex103.htm
EX-10.2 - EX-10.2 - AILERON THERAPEUTICS INCd14176dex102.htm
EX-10.1 - EX-10.1 - AILERON THERAPEUTICS INCd14176dex101.htm
EX-4.2 - EX-4.2 - AILERON THERAPEUTICS INCd14176dex42.htm
EX-3.2 - EX-3.2 - AILERON THERAPEUTICS INCd14176dex32.htm
EX-3.1 - EX-3.1 - AILERON THERAPEUTICS INCd14176dex31.htm
S-1 - S-1 - AILERON THERAPEUTICS INCd14176ds1.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Aileron Therapeutics, Inc. of our report dated April 14, 2017 relating to the financial statements, which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

June 2, 2017

AILERON THERAPEUTICS INC Reports